Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mohammadreza Amini Moridani"'
Autor:
Abtin Heidarzadeh, Mohammadreza Amini Moridani, Saman Khoshmanesh, Samira Kazemi, Marziyeh Hajiaghabozorgi, Manoochehr Karami
Publikováno v:
International Journal of Infectious Diseases, Vol 128, Iss , Pp 212-222 (2023)
Objectives: The present study was conducted to estimate the effectiveness of (BBIBP)-CorV (Sinopharm), ChAdOx1-S/nCoV-19 (AZD1222, Oxford-AstraZeneca), rAd26-rAd5 (Gam-COVID-Vac, Sputnik V), and BIV1-CovIran (COVIran Barekat) and BBV152 COVAXIN (Bhar
Externí odkaz:
https://doaj.org/article/e9a5486c729b417cbd734422e920b43f
Autor:
Roqayeh Aliyari, Sepideh Mahdavi, Mostafa Enayatrad, Sajad Sahab-Negah, Sairan Nili, Mohammad Fereidooni, Parvin Mangolian shahrbabaki, Alireza Ansari-Moghaddam, Abtin Heidarzadeh, Fariba Shahraki-Sanavi, Mohammadreza Amini Moridani, Mansooreh Fateh, Hamidreza Khajeha, Zahra Emamian, Elahe Behmanesh, Hamid Sharifi, Mohammad Hassan Emamian
Publikováno v:
BMC Public Health, Vol 22, Iss 1, Pp 1-7 (2022)
Abstract Background New vaccines that are initially approved in clinical trials are not completely free of risks. Systematic vaccine safety surveillance is required for ensuring safety of vaccines. This study aimed to provide a protocol for safety mo
Externí odkaz:
https://doaj.org/article/0673065354e44d0ca75cfa9eacc976eb
Autor:
Abtin Heidarzadeh, Mohammadreza Amini Moridani, Saman Khoshmanesh, Samira Kazemi, Marziyeh Hajiaghabozorgi, Manoochehr Karami
Publikováno v:
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
The present study was conducted to estimate the effectiveness of BBIBP-CorV (Sinopharm), ChAdOx1-S/nCoV-19 (AZD1222, Oxford-AstraZeneca), rAd26-rAd5 (Gam-COVID-Vac, Sputnik V), and BIV1-CovIran (COVIran Barekat) and BBV152 COVAXIN (Bharat Biotech) va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b824d0a74d2b9ad536fc38b67df1737f
https://pubmed.ncbi.nlm.nih.gov/36572376
https://pubmed.ncbi.nlm.nih.gov/36572376
Autor:
Ali Hosseinzadeh, Sajad Sahab-Negah, Sairan Nili, Roqayeh Aliyari, Shahrbanoo Goli, Mohammad Fereidouni, Ali Alami, Mohsen Shati, Elham Ahmadnezhad, Shiva Mehravaran, Mansooreh Fateh, Hamidreza Khajeha, Zahra Emamian, Elahe Behmanesh, Sepideh Mahdavi, Mostafa Enayatrad, Parvin Mangolian Shahrbabaki, Alireza Ansari-Moghaddam, Abtin Heidarzadeh, Fariba Shahraki-Sanavi, Seyed Mohammad Hashemi Shahri, Mahlagha Dehghan, Mohammadreza Amini Moridani, Hossein Sheibani, Maryam Abbaszadeh, Reza Jafari, Maryam Valikhani, Ehsan Binesh, Hamid Vahedi, Reza Chaman, Rozita Khodashahi, Mahnaz Amini, Farahzad Jabbari Azad, Fariborz Rezaeitalab, Saeid Amel Jamehdar, Ali Eshraghi, Hamid Sharifi, Seyed Mehdi Hashemi Bajgani, Amin Mahdavi, Abdollah Jafarzadeh, Mehrdad Farokhnia, Saeedeh Ebrahimi, Abbas Pardakhti, Ebrahim Ghaderi, Hasan Soltani, Sedigh Jadidoleslami, Anoush Arianejad, Hamed Gavili, Borhan Moradveisi, Dina Motamedi, Hamed Zare, Toba Kazemi, Mohammad Hassan Emamian
Publikováno v:
Bulletin of the World Health Organization. 100(8)
To investigate the incidence of coronavirus disease 2019 (COVID-19) cases, hospitalizations and deaths in Iranians vaccinated with either AZD1222 Vaxzevria, CovIran® vaccine, SARS-CoV-2 Vaccine (Vero Cell), Inactivated (lnCoV) or Sputnik V.We enroll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d16d9ffbf43ef9edb2438f4772b650b6
https://pubmed.ncbi.nlm.nih.gov/35923277
https://pubmed.ncbi.nlm.nih.gov/35923277